Key result
ACTION registry tracks >1500 pediatric MCS patients across 48 centers, offering key real-world data.
Why the study?
The ACTION registry collects large-scale adjudicated data on pediatric mechanical circulatory support but has limitations that may affect interpretation of findings.
Understanding the strengths and limitations of the ACTION registry is essential for optimizing its utility in research and quality improvement for pediatric patients on mechanical circulatory support.
Answers are grounded in this paper and cite their sources.
Cautious interpretation of ACTION registry data is essential for pediatric mechanical circulatory support; leaves open need for prospective validation.
The Advanced Cardiac Therapies Improving Outcomes Network (ACTION) registry collects data and adjudicates adverse events on pediatric patients receiving mechanical circulatory support at participating centers. To date, the registry includes over 1500 patients from 48 centers. Data collected has been used for research publications, quality improvement projects, and the regulatory support of several ventricular assist devices. While this dataset is large and adjudicated, the registry has real limitations that may limit the interpretation of findings. A full understanding of potential biases and limitations allows researchers and clinicians to make meaningful conclusions from the patient population. This report reviews the strengths and limitations of the ACTION registry to ensure optimal utility among pediatric patients receiving mechanical circulatory support. It also suggests potential areas for improvement to facilitate best care of this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Kwiatkowski et al. (2024) conducted a review in pediatric patients receiving mechanical circulatory support (n=1,500). ACTION registry was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: